The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer | European Respiratory Society
Epidermal growth factor receptor - Wikipedia
Figure 1 | Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer
The paradoxical functions of EGFR during breast cancer progression | Signal Transduction and Targeted Therapy
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET - Journal of Biological Chemistry
Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
Mechanisms of EGFR inhibitor resistance and therapeutic strategies. | Download Scientific Diagram
Mechanism of action of EGFR inhibitors. TKIs and mAbs bind to the... | Download Scientific Diagram
Epidermal growth factor receptor in relation to tumor development: EGFR‐targeted anticancer therapy - Okamoto - 2010 - The FEBS Journal - Wiley Online Library
Cancers | Free Full-Text | Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies | HTML
Frontiers | The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells | Oncology
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
Clinical development of targeted and immune based anti-cancer therapies | Journal of Experimental & Clinical Cancer Research | Full Text
An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor: Cell
Understanding the EGFR mutation aids the fight against lung cancer - Research Outreach
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
A: Mechanism of action on EGFR family's proliferation pathway. Afatinib... | Download Scientific Diagram
Frontiers | EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies | Oncology
Dacoplice® | Pfizer India | Mechanism of action
Overcoming therapy resistance in EGFR-mutant lung cancer | Nature Cancer
Mechanisms of action of EGFR inhibitors | EGFR Inhibitors in Cancer Treatment
Mechanisms of resistance to EGFR tyrosine kinase inhibitors - ScienceDirect
Predicting the Molecular Mechanism of EGFR Domain II Dimer Binding Interface by Machine Learning to Identify Potent Small Molecule Inhibitor for Treatment of Cancer - Journal of Pharmaceutical Sciences
